カテゴリー： QYResearch, 世界

世界のクッシング症候群・先端巨大症治療市場規模・現状・予測2021-2027

【英語タイトル】Global Cushing's Syndrome and Acromegaly Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料（QY21APR1678）・商品コード：QY21APR1678
・発行会社（調査会社）：QYResearch
・発行日：2021年4月
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥518,700見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥778,050見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,037,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査資料では、クッシング症候群・先端巨大症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・クッシング症候群・先端巨大症治療の市場動向
・企業の競争状況、市場シェア
・クッシング症候群・先端巨大症治療の種類別市場規模（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）
・クッシング症候群・先端巨大症治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局）
・クッシング症候群・先端巨大症治療の北米市場規模2016-2027（アメリカ、カナダ）
・クッシング症候群・先端巨大症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・クッシング症候群・先端巨大症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・クッシング症候群・先端巨大症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・クッシング症候群・先端巨大症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、Bristol-Myers Squibb、Corcept Therapeutics、HRA Pharma、Ipsen Biopharmaceuticals）
・結論
【レポートの概要】

Cushing’s syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing’s syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly involves symptoms such as enlargement of the hands, feet, forehead, jaw, nose etc. resulting in joint pain, thickening of skin, deepening of the voice, headaches, and vision problems. Other complications include type 2 diabetes, and hypertension. Acromegaly is also caused by production of excess growth hormone (GH). Most cases of Acromegaly is due to the pituitary gland producing excessive growth hormone mostly due a benign tumor, known as a pituitary adenoma.
In terms of value, North America is expected to be the dominant regional market for Cushing’s Syndrome and Acromegaly treatment by 2025 and is expected to expand at a CAGR of 9% over the forecast period.

Market Analysis and Insights: Global Cushing’s Syndrome and Acromegaly Treatment Market
The global Cushing’s Syndrome and Acromegaly Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cushing’s Syndrome and Acromegaly Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cushing’s Syndrome and Acromegaly Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cushing’s Syndrome and Acromegaly Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cushing’s Syndrome and Acromegaly Treatment market.

Global Cushing’s Syndrome and Acromegaly Treatment Scope and Market Size
Cushing’s Syndrome and Acromegaly Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cushing’s Syndrome and Acromegaly Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Glucocorticoid Receptor Inhibitors
Somatostatin
Ketoconazole HRA
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Bristol-Myers Squibb
Corcept Therapeutics
HRA Pharma
Ipsen Biopharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Glucocorticoid Receptor Inhibitors
1.2.3 Somatostatin
1.2.4 Ketoconazole HRA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Perspective (2016-2027)
2.2 Cushing’s Syndrome and Acromegaly Treatment Growth Trends by Regions
2.2.1 Cushing’s Syndrome and Acromegaly Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cushing’s Syndrome and Acromegaly Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cushing’s Syndrome and Acromegaly Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cushing’s Syndrome and Acromegaly Treatment Industry Dynamic
2.3.1 Cushing’s Syndrome and Acromegaly Treatment Market Trends
2.3.2 Cushing’s Syndrome and Acromegaly Treatment Market Drivers
2.3.3 Cushing’s Syndrome and Acromegaly Treatment Market Challenges
2.3.4 Cushing’s Syndrome and Acromegaly Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cushing’s Syndrome and Acromegaly Treatment Players by Revenue
3.1.1 Global Top Cushing’s Syndrome and Acromegaly Treatment Players by Revenue (2016-2021)
3.1.2 Global Cushing’s Syndrome and Acromegaly Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cushing’s Syndrome and Acromegaly Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cushing’s Syndrome and Acromegaly Treatment Revenue
3.4 Global Cushing’s Syndrome and Acromegaly Treatment Market Concentration Ratio
3.4.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cushing’s Syndrome and Acromegaly Treatment Revenue in 2020
3.5 Cushing’s Syndrome and Acromegaly Treatment Key Players Head office and Area Served
3.6 Key Players Cushing’s Syndrome and Acromegaly Treatment Product Solution and Service
3.7 Date of Enter into Cushing’s Syndrome and Acromegaly Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cushing’s Syndrome and Acromegaly Treatment Breakdown Data by Type
4.1 Global Cushing’s Syndrome and Acromegaly Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cushing’s Syndrome and Acromegaly Treatment Forecasted Market Size by Type (2022-2027)

5 Cushing’s Syndrome and Acromegaly Treatment Breakdown Data by Application
5.1 Global Cushing’s Syndrome and Acromegaly Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cushing’s Syndrome and Acromegaly Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cushing’s Syndrome and Acromegaly Treatment Market Size (2016-2027)
6.2 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type
6.2.1 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2021)
6.2.2 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2022-2027)
6.2.3 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2027)
6.3 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application
6.3.1 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2021)
6.3.2 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2022-2027)
6.3.3 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2027)
6.4 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Country
6.4.1 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2016-2021)
6.4.2 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size (2016-2027)
7.2 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Type
7.2.1 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2027)
7.3 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Application
7.3.1 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2027)
7.4 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Country
7.4.1 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Type
8.2.1 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Application
8.3.1 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Region
8.4.1 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cushing’s Syndrome and Acromegaly Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size (2016-2027)
9.2 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type
9.2.1 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2027)
9.3 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application
9.3.1 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2027)
9.4 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Country
9.4.1 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Type
10.2.1 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Application
10.3.1 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Country
10.4.1 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cushing’s Syndrome and Acromegaly Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cushing’s Syndrome and Acromegaly Treatment Introduction
11.1.4 Pfizer Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cushing’s Syndrome and Acromegaly Treatment Introduction
11.2.4 Novartis Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Cushing’s Syndrome and Acromegaly Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Corcept Therapeutics
11.4.1 Corcept Therapeutics Company Details
11.4.2 Corcept Therapeutics Business Overview
11.4.3 Corcept Therapeutics Cushing’s Syndrome and Acromegaly Treatment Introduction
11.4.4 Corcept Therapeutics Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2016-2021)
11.4.5 Corcept Therapeutics Recent Development
11.5 HRA Pharma
11.5.1 HRA Pharma Company Details
11.5.2 HRA Pharma Business Overview
11.5.3 HRA Pharma Cushing’s Syndrome and Acromegaly Treatment Introduction
11.5.4 HRA Pharma Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2016-2021)
11.5.5 HRA Pharma Recent Development
11.6 Ipsen Biopharmaceuticals
11.6.1 Ipsen Biopharmaceuticals Company Details
11.6.2 Ipsen Biopharmaceuticals Business Overview
11.6.3 Ipsen Biopharmaceuticals Cushing’s Syndrome and Acromegaly Treatment Introduction
11.6.4 Ipsen Biopharmaceuticals Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2016-2021)
11.6.5 Ipsen Biopharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cushing's Syndrome and Acromegaly Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Glucocorticoid Receptor Inhibitors
Table 3. Key Players of Somatostatin
Table 4. Key Players of Ketoconazole HRA
Table 5. Key Players of Others
Table 6. Global Cushing's Syndrome and Acromegaly Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions (2016-2021)
Table 10. Global Cushing's Syndrome and Acromegaly Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions (2022-2027)
Table 12. Cushing's Syndrome and Acromegaly Treatment Market Trends
Table 13. Cushing's Syndrome and Acromegaly Treatment Market Drivers
Table 14. Cushing's Syndrome and Acromegaly Treatment Market Challenges
Table 15. Cushing's Syndrome and Acromegaly Treatment Market Restraints
Table 16. Global Cushing's Syndrome and Acromegaly Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Players (2016-2021)
Table 18. Global Top Cushing's Syndrome and Acromegaly Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing's Syndrome and Acromegaly Treatment as of 2020)
Table 19. Ranking of Global Top Cushing's Syndrome and Acromegaly Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cushing's Syndrome and Acromegaly Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cushing's Syndrome and Acromegaly Treatment Product Solution and Service
Table 23. Date of Enter into Cushing's Syndrome and Acromegaly Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Cushing's Syndrome and Acromegaly Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cushing's Syndrome and Acromegaly Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Cushing's Syndrome and Acromegaly Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Cushing's Syndrome and Acromegaly Treatment Product
Table 66. Pfizer Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Cushing's Syndrome and Acromegaly Treatment Product
Table 71. Novartis Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Product
Table 76. Bristol-Myers Squibb Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Corcept Therapeutics Company Details
Table 79. Corcept Therapeutics Business Overview
Table 80. Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Product
Table 81. Corcept Therapeutics Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021) & (US$ Million)
Table 82. Corcept Therapeutics Recent Development
Table 83. HRA Pharma Company Details
Table 84. HRA Pharma Business Overview
Table 85. HRA Pharma Cushing's Syndrome and Acromegaly Treatment Product
Table 86. HRA Pharma Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021) & (US$ Million)
Table 87. HRA Pharma Recent Development
Table 88. Ipsen Biopharmaceuticals Company Details
Table 89. Ipsen Biopharmaceuticals Business Overview
Table 90. Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Product
Table 91. Ipsen Biopharmaceuticals Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021) & (US$ Million)
Table 92. Ipsen Biopharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Type: 2020 VS 2027
Figure 2. Glucocorticoid Receptor Inhibitors Features
Figure 3. Somatostatin Features
Figure 4. Ketoconazole HRA Features
Figure 5. Others Features
Figure 6. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Cushing's Syndrome and Acromegaly Treatment Report Years Considered
Figure 11. Global Cushing's Syndrome and Acromegaly Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cushing's Syndrome and Acromegaly Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions (2022-2027)
Figure 15. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Players in 2020
Figure 16. Global Top Cushing's Syndrome and Acromegaly Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing's Syndrome and Acromegaly Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cushing's Syndrome and Acromegaly Treatment Revenue in 2020
Figure 18. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2016-2027)
Figure 22. North America Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2016-2027)
Figure 23. North America Cushing's Syndrome and Acromegaly Treatment Market Share by Country (2016-2027)
Figure 24. United States Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2016-2027)
Figure 28. Europe Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2016-2027)
Figure 29. Europe Cushing's Syndrome and Acromegaly Treatment Market Share by Country (2016-2027)
Figure 30. Germany Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cushing's Syndrome and Acromegaly Treatment Market Share by Region (2016-2027)
Figure 40. China Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Cushing's Syndrome and Acromegaly Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021)
Figure 62. Corcept Therapeutics Revenue Growth Rate in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021)
Figure 63. HRA Pharma Revenue Growth Rate in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021)
Figure 64. Ipsen Biopharmaceuticals Revenue Growth Rate in Cushing's Syndrome and Acromegaly Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


【掲載企業】

Pfizer、Novartis、Bristol-Myers Squibb、Corcept Therapeutics、HRA Pharma、Ipsen Biopharmaceuticals

★調査レポート[世界のクッシング症候群・先端巨大症治療市場規模・現状・予測2021-2027] (コード：QY21APR1678)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のクッシング症候群・先端巨大症治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の先端巨大症治療市場規模・現状・予測2021-2027
    QY21APR0035 / QYResearch / 2021年4月 / 本調査資料では、先端巨大症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（異所性先端巨大症、偽先端巨大症）、用途別市場規模（手術、薬物療法、放射線療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・先端巨大症治療の市場動向 ・企業の競争状況、市場シェア ・先端巨大症治療の種類別市場規模（異所性先端巨大症、偽先端巨大症） ・先端巨大症治療の用途別市場規模（手術、薬物療法、放射線療法） ・先端巨大症治療の北米市場規模2016-2027（アメリカ、カナダ） ・先端巨大症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・先端巨大症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・先端巨大症治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Acromegaly Treatment Market The global Acromegaly Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acromegaly Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acromegaly Treatment market in terms of revenue. On the...
  • 世界の先端巨大症治療市場規模・現状・予測2021-2027
    QY21APR0034 / QYResearch / 2021年4月 / 本調査資料では、先端巨大症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オクトレオチド、パシレオチド、ランレオチド、ペグビソマント）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・先端巨大症治療の市場動向 ・企業の競争状況、市場シェア ・先端巨大症治療の種類別市場規模（オクトレオチド、パシレオチド、ランレオチド、ペグビソマント） ・先端巨大症治療の用途別市場規模（病院、薬局） ・先端巨大症治療の北米市場規模2016-2027（アメリカ、カナダ） ・先端巨大症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・先端巨大症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・先端巨大症治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. Market Analysis and Insights: Global Acromegaly Therapeutics Market The global Acromegaly Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acromegaly Therapeutics market to help players in achieving a strong market position. Buyers of the report can...
  • 世界のドラベ症候群治療市場規模・現状・予測2021-2027
    QY21APR1961 / QYResearch / 2021年4月 / 本調査資料では、ドラベ症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））、用途別市場規模（病院薬局、小売薬局、Eコマース、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ドラベ症候群治療の市場動向 ・企業の競争状況、市場シェア ・ドラベ症候群治療の種類別市場規模（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD）） ・ドラベ症候群治療の用途別市場規模（病院薬局、小売薬局、Eコマース、その他） ・ドラベ症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・ドラベ症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ドラベ症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ドラベ症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet. Market Analysis and Insights: Global Dravet Syndrome Treatment Market The global Dravet Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019,...
  • 世界のバーター症候群治療市場規模・現状・予測2021-2027
    QY21APR0705 / QYResearch / 2021年4月 / 本調査資料では、バーター症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・バーター症候群治療の市場動向 ・企業の競争状況、市場シェア ・バーター症候群治療の種類別市場規模（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他） ・バーター症候群治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・バーター症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・バーター症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・バーター症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バーター症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bartter Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bartter Syndrome Treatment market to help...
  • 世界のクッシング症候群治療市場規模・現状・予測2021-2027
    QY21APR1679 / QYResearch / 2021年4月 / 本調査資料では、クッシング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・クッシング症候群治療の市場動向 ・企業の競争状況、市場シェア ・クッシング症候群治療の種類別市場規模（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他） ・クッシング症候群治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・クッシング症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・クッシング症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・クッシング症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クッシング症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of value, North America is expected to be the dominant regional market for Cushing’s Syndrome treatment by 2025 and is expected to expand at a CAGR of 9% over the forecast period. Market Analysis and Insights: Global Cushing's Syndrome Treatment Market The global Cushing's Syndrome Treatment market size is projected to reach US$ XX million by...
  • 世界の多嚢胞性卵巣症候群治療市場規模・現状・予測2021-2027
    QY21APR4691 / QYResearch / 2021年4月 / 本調査資料では、多嚢胞性卵巣症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤＆SERM、利尿剤）、用途別市場規模（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・多嚢胞性卵巣症候群治療の市場動向 ・企業の競争状況、市場シェア ・多嚢胞性卵巣症候群治療の種類別市場規模（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤＆SERM、利尿剤） ・多嚢胞性卵巣症候群治療の用途別市場規模（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック） ・多嚢胞性卵巣症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・多嚢胞性卵巣症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・多嚢胞性卵巣症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多嚢胞性卵巣症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velvety skin. Market Analysis and Insights: Global Polycystic Ovarian Syndrome Treatment Market The global Polycystic Ovarian Syndrome Treatment market size is projected to reach US$ 3786.5 million by 2026, from US$ 3106.6 million in 2019, at a CAGR of 2.8% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a...
  • 世界の複合性局所疼痛症候群治療市場規模・現状・予測2021-2027
    QY21APR1509 / QYResearch / 2021年4月 / 本調査資料では、複合性局所疼痛症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（T-121、NTRX-07、ネリドロン酸、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・複合性局所疼痛症候群治療の市場動向 ・企業の競争状況、市場シェア ・複合性局所疼痛症候群治療の種類別市場規模（T-121、NTRX-07、ネリドロン酸、その他） ・複合性局所疼痛症候群治療の用途別市場規模（病院、クリニック、その他） ・複合性局所疼痛症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・複合性局所疼痛症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・複合性局所疼痛症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・複合性局所疼痛症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Market Analysis and Insights: Global Complex Regional Pain Syndrome Treatment Market The global Complex Regional Pain Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Complex Regional Pain Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global...
  • 世界の慢性疲労症候群治療市場規模・現状・予測2021-2027
    QY21APR1312 / QYResearch / 2021年4月 / 本調査資料では、慢性疲労症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫増強剤・抗ウイルス剤、睡眠増強、CNS（中枢神経系）刺激剤）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・慢性疲労症候群治療の市場動向 ・企業の競争状況、市場シェア ・慢性疲労症候群治療の種類別市場規模（免疫増強剤・抗ウイルス剤、睡眠増強、CNS（中枢神経系）刺激剤） ・慢性疲労症候群治療の用途別市場規模（病院、クリニック、研究機関） ・慢性疲労症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性疲労症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性疲労症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性疲労症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Chronic fatigue syndrome is not a simple problem for any individual, it’s a complex disorder which is considered as thrilling fatigue, which cannot be able to explain by medical conditions. Chronic fatigue syndrome which can prime to deterioration of creatively suffering and harm of quality of life, happiness and mental peace. Chronic fatigue is also known as myalgic encephalomyelitis or encephalopathy which is a complex debilitating disorder, which can affect human normal life style. The cause of chronic fatigue syndrome is not clearly known still today, the researcher are actively working to find the cause of chronic fatigue syndrome, as...
  • 世界の過敏性腸症候群治療市場規模・現状・予測2021-2027
    QY21APR3283 / QYResearch / 2021年4月 / 本調査資料では、過敏性腸症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（便秘過敏性腸症候群、下痢過敏性腸症候群、便秘・下痢過敏性腸症候群）、用途別市場規模（病院、クリニック、在宅ケア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・過敏性腸症候群治療の市場動向 ・企業の競争状況、市場シェア ・過敏性腸症候群治療の種類別市場規模（便秘過敏性腸症候群、下痢過敏性腸症候群、便秘・下痢過敏性腸症候群） ・過敏性腸症候群治療の用途別市場規模（病院、クリニック、在宅ケア） ・過敏性腸症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・過敏性腸症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・過敏性腸症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・過敏性腸症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms. Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the...
  • 世界のアスペルガー症候群治療市場規模・現状・予測2021-2027
    QY21APR0477 / QYResearch / 2021年4月 / 本調査資料では、アスペルガー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、言語療法、作業療法）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アスペルガー症候群治療の市場動向 ・企業の競争状況、市場シェア ・アスペルガー症候群治療の種類別市場規模（薬物療法、言語療法、作業療法） ・アスペルガー症候群治療の用途別市場規模（病院、クリニック、ドラッグストア、その他） ・アスペルガー症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・アスペルガー症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アスペルガー症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アスペルガー症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）...The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence and language development. Although they may develop problems while communicating as they get older. Some of the common symptoms of the Asperger syndrome include repetitive behaviors, unusual preoccupations or rituals, limited range of interests, problems with social skills, communication difficulties, and coordination problems. Market Analysis and Insights: Global Asperger Syndrome Treatment Market The global Asperger Syndrome...

    • ◆H&Iグローバルリサーチのお客様（例）◆